Trump's tariff timeline gives two years of zero duty on drug imports, then 100% for a year, then 200%. Indian pharma stocks and eight other names from Maruti to Anant Raj drive the session.
US President Donald Trump said drugs imported into the United States will face no tariff for two years, then a 100% charge for one year, and 200% after that. The post on Truth Social frames the timeline to "RESHORE Generic Pharmaceutical Production into America," with a penalty for companies that do not build within the period. Indian pharma stocks, heavy in the US generic market, are set to open with the clock running on a three-step escalation.
Maruti Suzuki India Ltd announced a fresh price hike of up to Rs 30,000 across its vehicle portfolio. The company cited persistent inflationary pressures and a challenging cost environment. Revised prices take effect from August 2026, with the exact increase varying by model and variant, Maruti said in a regulatory filing. The move comes as input costs remain elevated and the broader auto sector watches demand elasticity.
Purple Finance Ltd has in-principle approval to acquire a 100% equity stake in Saksham Gram Credit Private Limited. The deal targets rural and semi-urban retail lending expansion. The final cost, valuation, structure, and payment terms – cash or share swap – are under discussion and will be fixed upon signing definitive agreements.
Anant Raj Limited's board approved a Composite Scheme of Arrangement to restructure its data centre and cloud operations. The plan first consolidates all digital infrastructure under one entity, then carves it into Ashok Cloud Pvt Limited for independent listing. Eligible Anant Raj shareholders will receive one Ashok Cloud equity share of face value Rs 2 for each Anant Raj share of the same face value held. The restructuring splits real estate and digital infrastructure into separate focused businesses.
Anupam Rasayan India Ltd launched an open offer to public shareholders of Bliss GVS Pharma Ltd. The offer covers up to 2,77,26,848 fully paid-up equity shares, representing 26% of expanded voting capital, at Rs 299 per share. Anupam Rasayan, together with Mates Visa Consultancy Private Limited as PAC, is making the mandatory offer. Anupam had earlier signed a definitive pact to acquire a 43.3% to 48.2% stake in Bliss GVS Pharma for up to Rs 1,369.51 crore.
PC Jeweller has cleared and repaid all outstanding debt under its September 30, 2024 settlement agreement with one more bank. The company has now repaid all debt for 5 of the 14 consortium banks.
Zen Technologies Ltd received an order worth Rs 177.5 crore, including GST, for upgrading and integrating Tank and Crew Gunnery Simulators from the Ministry of Defence.
CuraTeQ Biologics Pvt Ltd, a wholly owned subsidiary of Aurobindo Pharma Ltd, received approval from ANVISA, Brazil's health surveillance agency, for its biosimilars manufacturing facility in Hyderabad. The facility underwent a GMP inspection from May 11 to May 15, 2026. The approval covers biological API and sterile products, including four biosimilar products across mammalian and microbial manufacturing, prefillable syringe and vial filling, packaging and labeling, and QC testing.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.